Andrea Vidali, MD

Andrea Vidali, MD has a diverse work experience in the medical field. Andrea is currently the Founder, President, and CEO of Pregmune, a testing and reporting platform for the immunological evaluation of miscarriage, infertility, and IVF. This platform is being developed by the medical and scientific team of Braverman Reproductive Immunology. Prior to this, they worked as a Robotic Surgeon and Scientist at Andrea Vidali MD since 1996.

Andrea Vidali, MD completed their education at Universita' di padova from 1982 to 1988, where they obtained their MD degree with a focus on Infertility and Reproductive Medicine. In addition, they pursued further specialization at Columbia University Vagelos College of Physicians and Surgeons, where they studied Reproductive Endocrinology/Infertility, although the specific dates of this program are unavailable. Additionally, Dr. Vidali completed their residency in ob/gyn at Georgetown University School of Medicine, but the duration of this residency is unknown.